Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous Urticaria
Allergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.
What Conferences Are You Planning to Attend in Quarter 2 of 2024?
Ahead of the next 3 months of the year, Dermatology Times wants to know what conferences and meetings you plan to attend between April and June. Share your thoughts with us by March 27.
2024 AAD Annual Meeting Recap: Day 5
Catch up on coverage from the fifth and final day of the 2024 American Academy of Dermatology Annual Meeting.
How Can Patients Benefit From New Device, TruFacial?
Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.
What’s New in Hair Loss Therapies and Exosomes?
Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.
Catching Up With Karan Lal, DO, MS FAAD
In between sessions, Lal shared his favorite pearls from AAD, a recent challenging pediatric case in his practice, the significance of LinkedIn, and more.
Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment Tips
Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.
Environmental Factors Affecting Pigmentation And The Skin Exposome
Arianne Shadi Kourosh, MD, MPH, FAAD, shared pearls on environmental factors that can impact skin aging and pigmentation including visible light, IR radiation, location, and pollution.
Serving Those Who Serve Our Communities: Melanoma in Veterans and Firefighters
Rebecca Hartman, MD, MPH, FAAD, and Christine Kannler, MD, FAAD, took a deep dive into considerations and pearls to treat patients who have been exposed to extreme heat and chemicals in the line of duty.
Red, Itchy, And AD Until Proven Otherwise
Raj Chovatiya, MD, PhD, delves into the conditions that could be red, itchy, and not atopic dermatitis. He explains the importance of knowing characteristics for various inflammatory conditions.
Advocating for Increased Representation of Women in Dermatology
The Bristol Myers Squibb-hosted event brought together a panel of leading women in dermatology to discuss the challenges they’ve faced and how women can support each other.
Cheri Frey, MD, FAAD: Exploring Cosmeceutical Ingredients and Their Role in Skin Health
Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.
Late-Breaking Data: Povorcitinib Significantly Improves Itch and Lesions in Prurigo Nodularis
Shawn Kwatra, MD, shares positive updates on phase 2 oral povorcitinib for prurigo nodularis at AAD 2024.
When Comparing JAKs to Immunomodulators, Analysis Revealed Equal or Lower Incidence Rates For Major Adverse Events
Presented at the American Academy of Dermatology Annual Meeting, the poster was the winner of the third place poster award.
Lisa Swanson, MD, FAAD: Clinical Pearls and Updates for Pediatric Dermatology
Swanson shared updates and a look ahead at what is in store for pediatric dermatology.
Research Presented at AAD Explores Relationship Between Vitiligo and Skin Tone Bias in Google Searches
Several posters presented at the American Academy of Dermatology Annual Meeting explored the topic of skin tone bias related to vitiligo in Google and internet search platforms.
2024 AAD Annual Meeting Recap: Day 4
Catch up on coverage from the fourth day of the 2024 American Academy of Dermatology Annual Meeting.
Award-Winning Research on Hair Loss Consensus Highlighted at Annual Meeting
The poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
Updates on Benzene in Benzoyl Peroxide Products at AAD
Christopher Bunick, MD, PhD, presented updates and new data on the recent news of benzene found in benzoyl peroxide products.
American Academy of Dermatology Upholds Diversity Policies in Face of Anti-DEI Proposal
A vote during the annual meeting will keep DEI initiatives in place and members are awaiting news on what those initiatives will look like.